Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neurofibromatosis 1 × Doxorubicin × 1 year × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 39 Breast Neoplasms 27 Lymphoma 24 Precursor Cell Lymphoblastic Leukemia-Lymphoma 22 Sarcoma 21 Hodgkin Disease 20 Burkitt Lymphoma 20 Triple Negative Breast Neoplasms 18 Lymphoma, Follicular 14 Lymphoma, B-Cell 13 Ovarian Neoplasms 11 Neoplasms 10 Lymphoma, Non-Hodgkin 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma, T-Cell, Peripheral 8 Lymphoma, Mantle-Cell 8 Endometrial Neoplasms 8 Neoplasm Metastasis 6 Multiple Myeloma 6 Lymphoma, B-Cell, Marginal Zone 6 Liposarcoma 6 Leukemia 6 Recurrence 5 Osteosarcoma 5 Neuroblastoma 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Leiomyosarcoma 5 Fallopian Tube Neoplasms 5 Urinary Bladder Neoplasms 4 Sarcoma, Ewing 4

Interventions

AZD 6244 11 trametinib 2 Lasers, Solid-State 2 Deoxycholic Acid 2 thymoglobulin 1 talimogene laherparepvec 1 omipalisib 1 mirdametinib 1 fludarabine 1 dabrafenib 1 cabozantinib 1 binimetinib 1 Waiting Lists 1 Vincristine 1 Specimen Handling 1 Rituximab 1 Polidocanol 1 Photochemotherapy 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Lovastatin 1 Liquid Biopsy 1 Levetiracetam 1 Lasers 1 Inhalation 1 Dosage Forms 1 Cyclophosphamide 1 Curcumin 1 Carboplatin 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡